These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25987536)

  • 21. IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).
    Moon SH; Cho KH; Lee CG; Keum KC; Kim YS; Wu HG; Kim JH; Ahn YC; Oh D; Lee JH
    Strahlenther Onkol; 2016 Jun; 192(6):377-85. PubMed ID: 26972085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effectiveness and cost-effectiveness of endoscopic nasopharyngectomy versus intensity-modulated radiotherapy in the treatment of recurrent nasopharyngeal carcinoma: A microsimulation analysis.
    Rui M; Wang Y
    Head Neck; 2024 Sep; ():. PubMed ID: 39311280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma.
    OuYang PY; Shi D; Sun R; Zhu YJ; Xiao Y; Zhang LN; Zhang XH; Chen ZY; Lan XW; Tang J; Gao YH; Ma J; Deng W; Xie FY
    Oncotarget; 2016 May; 7(22):33408-17. PubMed ID: 27058901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the treatment outcomes of intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in nasopharyngeal carcinoma patients with parapharyngeal space extension.
    Tang LL; Chen L; Mao YP; Li WF; Sun Y; Liu LZ; Lin AH; Mai HQ; Shao JY; Li L; Ma J
    Radiother Oncol; 2015 Aug; 116(2):167-73. PubMed ID: 26316395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Ho AS; Kaplan MJ; Fee WE; Yao M; Sunwoo JB; Hwang PH
    Int Forum Allergy Rhinol; 2012; 2(2):166-73. PubMed ID: 22170783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.
    Lee VH; Kwong DL; Leung TW; Ng SC; Lam KO; Tong CC; Sze CK
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1067-1078. PubMed ID: 27738820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.
    You R; Sun R; Hua YJ; Li CF; Li JB; Zou X; Yang Q; Liu YP; Zhang YN; Yu T; Cao JY; Zhang MX; Jiang R; Mo HY; Guo L; Cao KJ; Lin AH; Qian CN; Sun Y; Ma J; Chen MY
    Int J Cancer; 2017 Sep; 141(6):1265-1276. PubMed ID: 28577306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
    Yue Q; Zhang M; Chen Y; Zheng D; Chen Y; Feng M
    Oral Oncol; 2018 Jun; 81():81-88. PubMed ID: 29884418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system.
    You R; Zou X; Wang SL; Jiang R; Tang LQ; Zhang WD; Li L; Zhang MX; Shen GP; Guo L; Qian CN; Mai HQ; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Sep; 51(13):1771-9. PubMed ID: 26055204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM; Guan Y; Xiao WW; Zeng L; Liu S; Lu TX; Zhao C; Han F
    Head Neck; 2016 Feb; 38(2):225-31. PubMed ID: 25244494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of clinical prognosis of endoscopic salvage surgery in patients with rT2 recurrent nasopharyngeal carcinoma].
    Song XL; Li WP; Yang JY; Zhang HK; Wang H; Xue K; Liu Q; Sun XC; Yu HM; Wang DH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1442-1449. PubMed ID: 36707948
    [No Abstract]   [Full Text] [Related]  

  • 36. Strategies for patients with recurrent nasopharyngeal carcinoma involved internal carotid artery who are intolerant to embolization.
    Wu WB; Zhang XB; Feng ZK; Li HF; Liu YP; Liang JL; Xie YL; Hua YJ; Sun R; Wang SL; Chen JH; Chen MY
    Rhinology; 2024 Jun; 62(3):342-352. PubMed ID: 38078376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcomes and prognostic factors of re-irradiation for locally recurrent nasopharyngeal carcinoma using intensity-modulated radiotherapy.
    Han F; Zhao C; Huang SM; Lu LX; Huang Y; Deng XW; Mai WY; Teh BS; Butler EB; Lu TX
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):569-76. PubMed ID: 22209574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG.
    Ng WT; Wong ECY; Cheung AKW; Chow JCH; Poon DMC; Lai JWY; Chiang CL; Choi HCW; Chau TC; Lee VHF; Lee AWM; Tam AHP; Au KH
    Head Neck; 2019 Oct; 41(10):3661-3669. PubMed ID: 31350940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent nasopharyngeal carcinoma after salvage nasopharyngectomy.
    Chan JY; Wei WI
    Arch Otolaryngol Head Neck Surg; 2012 Jun; 138(6):572-6. PubMed ID: 22710509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.